27 related articles for article (PubMed ID: 17673375)
1. CHFR and Paclitaxel Sensitivity of Ovarian Cancer.
Wahner Hendrickson AE; Visscher DW; Hou X; Goergen KM; Atkinson HJ; Beito TG; Negron V; Lingle WL; Bruzek AK; Hurley RM; Wagner JM; Flatten KS; Peterson KL; Schneider PA; Larson MC; Maurer MJ; Kalli KR; Oberg AL; Weroha SJ; Kaufmann SH
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885153
[TBL] [Abstract][Full Text] [Related]
2. CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.
Privette LM; Petty EM
Transl Oncol; 2008 Jul; 1(2):57-64. PubMed ID: 18633460
[TBL] [Abstract][Full Text] [Related]
3. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer.
Tokunaga E; Oki E; Nishida K; Koga T; Yoshida R; Ikeda K; Kojima A; Egashira A; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2006 May; 97(2):199-203. PubMed ID: 16502017
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers.
Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG
Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
[TBL] [Abstract][Full Text] [Related]
6. Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.
Mariatos G; Bothos J; Zacharatos P; Summers MK; Scolnick DM; Kittas C; Halazonetis TD; Gorgoulis VG
Cancer Res; 2003 Nov; 63(21):7185-9. PubMed ID: 14612512
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma.
Sakai M; Hibi K; Kanazumi N; Nomoto S; Inoue S; Takeda S; Nakao A
Hepatogastroenterology; 2005; 52(66):1854-7. PubMed ID: 16334792
[TBL] [Abstract][Full Text] [Related]
8. CHFR gene is neither mutated nor hypermethylated in ovarian cancer.
Ludwig AH; Bujko M; Bidzinski M; Kupryjańczyk J
Cancer Detect Prev; 2007; 31(3):257-61. PubMed ID: 17673375
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and ovarian cancer.
Nephew KP; Balch C; Zhang S; Huang TH
Cancer Treat Res; 2009; 149():131-46. PubMed ID: 19763434
[No Abstract] [Full Text] [Related]
10. CHFR: a key checkpoint component implicated in a wide range of cancers.
Sanbhnani S; Yeong FM
Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584
[TBL] [Abstract][Full Text] [Related]
11. Aberrant epithelial differentiation in ovarian cancer.
Smith ER; Cai KQ; Capo-Chichi CD; Xu X
Cancer Treat Res; 2009; 149():147-63. PubMed ID: 19763435
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
